Feature

Engineering Safer Editors for Cystic Fibrosis Mutations 

Modified APOBEC3G editors improve CRISPR base-editing specificity and reduce bystander mutations in human cells

  • March 13, 2026

  • 2 min

Share

  • 1

    New DNA base-editing tools developed for cystic fibrosis.

  • 2

    Focus on cytosine base editors (CBEs) to improve precision.

  • 3

    Unintended edits reduced to less than 1%.

  • 4

    Editors successful in correcting mutations in human cells.

  • 5

    Potential for gene therapies and cellular models in research.

Original Source(s)

Engineering Safer Editors for Cystic Fibrosis Mutations 

  • March 13, 2026

Related Content

Building Quality into Advanced Therapies from Day One

Why early, risk-based thinking is critical in cell and gene therapy development

  • March 13, 2026

  • 7 min
The Genetic Switch in Pancreatic Cancer 

New research explains how a common cancer gene alters tumor type and may influence treatment response

  • March 13, 2026

  • 3 min
Deep-UV Raman Reveals mRNA Encapsulation in Lipid Nanoparticles 

Spectroscopic analysis reveals lipid–RNA interactions governing nanoparticle formulation efficiency 

  • March 13, 2026

  • 2 min